NCT04551950
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04551950
Title Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTRAPID 046)
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Stanford Health Care Hospital & Clinics Stanford California 94305 United States Details
Augusta University - formerly Georgia Regents University Augusta Georgia 30912 United States Details
Comprehensive Cancer Centers of Nevada Henderson Nevada 89074 United States Details
University of Cincinnati Physicians Group, LLC - Pharmatech Oncology, Inc Cincinnati Ohio 45206 United States Details
UT Southwestern Medical Center Dallas Texas 75390 United States Details
National Cancer Center Hospital Chūōku Japan Details
Saitama Medical University International Medical Center Hidaka-shi Japan Details
Cancer Institute Hospital of JFCR Kōtoku Japan Details
Osaka International Cancer Institute Osaka Japan Details
Shizuoka Cancer Center Sunto-gun Japan Details
Hospital Clinic i Provincial de Barcelona - Servicio de Oncologia Barcelona Spain Details
Hospital Universitari Vall d'Hebron - Dept of Oncology Barcelona Spain Details
ICO l´Hospitalet - Hospital Duran i Reynals - Servicio de Oncologia Barcelona Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field